Latest News and Press Releases
Want to stay updated on the latest news?
-
Robbins LLP is Investigating Allegations that REGENXBIO, Inc. (RGNX) Misled Investors Regarding the Viability of its Drug Candidate RGX-111
-
Robbins LLP is Investigating Allegations that Ostin Technology Group Co., Ltd. (OST) Engaged in a Pump-and-Dump Scheme that Defrauded Investors
-
Robbins LLP is Investigating Allegations that Mereo BioPharma Group plc (MREO) Misled Investors Regarding Phase 3 Orbit and Cosmic Studies for Setrusumab
-
Robbins LLP is Investigating Allegations that Ultragenyx Pharmaceutical Inc. (RARE) Misled Investors Regarding Phase III Orbit and Cosmic Studies
-
Robbins LLP is Investigating Allegations that Ramaco Resources, Inc. (METC) Overstated Development Progress at the Company's Brook Mine
-
Robbins LLP is Investigating Allegations that Oracle Corporation (ORCL) Misled Investors Regarding its Data Center Capabilities for AI Infrastructure
-
Robbins LLP is Investigating Allegations that BlackRock TCP Capital Corp. (TCPC) Misled Investors Regarding its Business Prospects
-
Robbins LLP is Investigating Allegations that Agilon Health, Inc. (AGL) Misled Investors Regarding its Business Prospects
-
Robbins LLP is Investigating Allegations that Kyndryl Holdings, Inc. (KD) Materially Misstated its Financial Statements
-
The Allegations: Robbins LLP is Investigating Allegations that uniQure (QURE) Misled Investors Regarding the Likelihood of FDA Approval of its Drug.